Healthcare & Life Sciences
Innovation, technology, cost pressures, and regulatory changes are shaping the industry, requiring effective risk management and alignment of global and local strategies.
The increasing innovation, the interplay between drugs, devices, and technology, cost pressures, geopolitical tensions and the demand for patient-centricity care have created a dynamic environment for healthcare and life sciences companies. Businesses rely on Baker McKenzie to navigate new markets, enhance operational efficiency, and develop a pipeline of innovative products. Our commercial legal advice helps anticipate and manage risks, ensuring alignment between global strategy and the law, ultimately enabling companies to deliver superior patient care worldwide.
We offer a full suite of advice, including M&A, reorganizations, carve-outs, divestitures, collaborations, licensing and other commercial arrangements, tax, regulatory compliance, data and technology, IP, advertising and promotion, employment and compensation, ESG and sustainability, competition, supply chains, trade, product safety and liability, and litigation.
Our sector experience
Baker McKenzie acted as lead counsel for Acorda Therapeutics, formerly a public company listed on NASDAQ, in its USD 185 million sale of substantially all its assets to Merz Therapeutics.
The sale was implemented under the protection of Chapter 11 of the U.S. Bankruptcy Code that involved the restructuring of USD 207 million in secured public bond debt pursuant to a Restructuring Support Agreement pursuant to a Chapter 11 Plan and a going-concern section 363 sale of INBRIJA, AMPYRA, and FAMPYRA.
Acorda Therapeutics
Case study
Since President Donald Trump took office, import tariffs have become the priority trade issue, posing unique challenges for the pharmaceutical and medtech industries.
The Impact of Tariffs on the Life Sciences Industry
Read More
READ MORE
Novonesis
EUR 1.5 billion
Advised Novonesis in EUR 1.5 billion acquisition of dsm-firmenich’s share of the Feed Enzyme Alliance.
Lundbeck USD 2.6 billion
Lundbeck on an agreement to acquire Longboard Pharmaceuticals, Inc. for approximately USD 2.6 billion.
Baxter
USD 3.8 billion
Advised Baxter on the divestiture of Vantive Kidney Care Segment to Carlyle, the deal spanning over 45 jurisdictions.
Learn about our sector specific legal expertise
We help clients manage risks and align global strategy with local law, leveraging our experts' in-house experience in big pharma and biotech.
GET IN TOUCH
How can we help
Global Chair
Vanina Caniza
The team at Baker McKenzie have a pragmatic and hands-on approach and broad knowledge in pharma, life sciences and healthcare topics.
Global, Chambers & Partners, 2025
North America
Randall Sunberg
EMEA
Roel Meers
APAC
Vivian Wu
Latin America
Henrique Frizzo (Trench Rossi Watanabe)*
Pharmaceuticals & Biotech
Medical Devices
Consumer Health
News & Insight
Read Article
Baker McKenzie Assists Mission Barns in Obtaining Precedent Setting FDA Clearance
INSIGHT I LATEST THINKING
Read Article
Three Driving Forces for Healthcare and Life Sciences Transactions
INSIGHT
Read More
Hot in Healthcare.
Your go-to blog for Healthcare and Life Sciences updates
INSIGHT
Read More
Unlocking and Accelerating Growth: Healthcare and Life Sciences in Asia Pacific
INSIGHT
Read More
Quick Guide to Market Access in the Latin America Healthcare and Life Sciences Sector
NEWS
View all news
View legal alerts
Related services
Antitrust & Competition
Artificial Intelligence
Dispute Resolution
Get advice to find stability in a volatile environment, navigate the interplay between devices and tech, respond to competition from connected tech players, and manage cost pressures on your pipeline products and services.
How can we help
Consumer health companies navigating commercial, regulatory, IP and licensing, employment, compliance and tax complexities.
How can we help
Read More
Capital Markets
Data, Technology, Privacy & Cybersecurity
Tax
Sustainability and ESG
Supply Chains
Mergers & Acquisitions
Life Sciences Transactions
Investigations, Compliance & Ethics
International Commercial & Trade
Intellectual Property
FDA
Employment & Compensation
*Trench Rossi Watanabe (Brazil) and Baker McKenzie have executed a strategic cooperation agreement to consult on foreign law.
Digital Health